As of Jul 31
| +0.07 / +0.21%|
The 3 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 34.00. The median estimate represents a +21.84% increase from the last price of 32.83.
The current consensus among 3 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.